- Primary immunization with two doses of any COVID vaccine provided limited protection against Omicron. A booster increased protection but only temporarily. https://www.nejm.org/doi/full/10.1056/NEJMoa2119451 236 comments science
Linking pages
- JCM | Free Full-Text | Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe https://www.mdpi.com/2077-0383/13/2/334 19 comments
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203965 15 comments
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://doi.org/10.1056/NEJMoa2203965 15 comments
- Vaccines | Free Full-Text | Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review https://www.mdpi.com/2076-393X/11/1/24 9 comments
- Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies - International Journal of Infectious Diseases https://www.ijidonline.com/article/S1201-9712(23)00102-9/fulltext#seccesectitle0003 6 comments
- Requiem for the COVID Regime: Last Week in Liberty 11/27/22 https://lwil.substack.com/p/requiem-for-the-covid-regime-last?sd=pf 2 comments
Linked pages
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2101765?query=featured_home 528 comments
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern 379 comments
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 50 comments
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel | NEJM https://www.nejm.org/doi/10.1056/nejmoa2114255 10 comments
- Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109908 6 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf 0 comments
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2104974 0 comments
Related searches:
Search whole site: site:doi.org
Search title: Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM
See how to search.